Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

Published:2015-03-27 Issue:9 Volume:29 Page:1799-1810
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Parrish C,Scott G B,Migneco G,Scott K J,Steele L P,Ilett E,West E J,Hall K,Selby P J,Buchanan D,Varghese A,Cragg M S,Coffey M,Hillmen P,Melcher A A,Errington-Mais F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201588.pdf

Reference62 articles.

1. Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM et al. Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia. Br J Haematology 2008; 141: 607–614.

2. Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS . Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 2010; 95: 135–143.

3. Nabhan C, Coutre S, Hillmen P . Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime? Br J Haematol 2007; 136: 379–392.

4. Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS et al. Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. N Engl J Med 2014; 370: 2286–2294.

5. Glennie MJ, French RR, Cragg MS, Taylor RP . Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol Immunol 2007; 44: 3823–3837.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human umbilical cord mesenchymal stem cell exosomes deliver potent oncolytic reovirus to acute myeloid leukemia cells;Virology;2024-10

2. Oncolytic Viruses in Cancer Immunotherapy;Advanced Therapeutics;2024-05-22

3. The combination therapy of oncolytic virotherapy;Frontiers in Pharmacology;2024-04-25

4. Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial;Clinical Cancer Research;2023-10-09

5. Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality;Frontiers in Immunology;2023-09-11